X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB GSK PHARMA UNICHEM LAB/
GSK PHARMA
 
P/E (TTM) x 33.2 64.6 51.4% View Chart
P/BV x 3.5 10.4 33.7% View Chart
Dividend Yield % 0.5 1.2 44.6%  

Financials

 UNICHEM LAB   GSK PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
GSK PHARMA
Mar-17
UNICHEM LAB/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3343,838 8.7%   
Low Rs1742,637 6.6%   
Sales per share (Unadj.) Rs146.9354.2 41.5%  
Earnings per share (Unadj.) Rs11.939.8 29.9%  
Cash flow per share (Unadj.) Rs16.242.9 37.8%  
Dividends per share (Unadj.) Rs2.0030.00 6.7%  
Dividend yield (eoy) %0.80.9 85.0%  
Book value per share (Unadj.) Rs105.1236.9 44.4%  
Shares outstanding (eoy) m90.8484.70 107.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.79.1 18.9%   
Avg P/E ratio x21.481.4 26.2%  
P/CF ratio (eoy) x15.775.5 20.8%  
Price / Book Value ratio x2.413.7 17.7%  
Dividend payout %16.875.4 22.3%   
Avg Mkt Cap Rs m23,073274,216 8.4%   
No. of employees `0005.74.7 120.8%   
Total wages/salary Rs m2,5584,830 53.0%   
Avg. sales/employee Rs Th2,352.56,387.0 36.8%   
Avg. wages/employee Rs Th450.91,028.3 43.8%   
Avg. net profit/employee Rs Th190.4717.1 26.6%   
INCOME DATA
Net Sales Rs m13,34630,000 44.5%  
Other income Rs m192728 26.4%   
Total revenues Rs m13,53830,728 44.1%   
Gross profit Rs m1,6394,190 39.1%  
Depreciation Rs m390263 148.3%   
Interest Rs m290-   
Profit before tax Rs m1,4124,655 30.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-35457 -7.7%   
Tax Rs m2931,744 16.8%   
Profit after tax Rs m1,0803,368 32.1%  
Gross profit margin %12.314.0 87.9%  
Effective tax rate %20.737.5 55.3%   
Net profit margin %8.111.2 72.1%  
BALANCE SHEET DATA
Current assets Rs m5,97916,742 35.7%   
Current liabilities Rs m2,4327,202 33.8%   
Net working cap to sales %26.631.8 83.6%  
Current ratio x2.52.3 105.8%  
Inventory Days Days6352 121.7%  
Debtors Days Days6021 290.5%  
Net fixed assets Rs m6,4038,635 74.1%   
Share capital Rs m182847 21.5%   
"Free" reserves Rs m9,29319,222 48.3%   
Net worth Rs m9,54820,069 47.6%   
Long term debt Rs m23010 2,304.0%   
Total assets Rs m12,84330,038 42.8%  
Interest coverage x50.0NM-  
Debt to equity ratio x00 4,842.5%  
Sales to assets ratio x1.01.0 104.0%   
Return on assets %8.611.2 77.0%  
Return on equity %11.316.8 67.4%  
Return on capital %14.325.5 56.3%  
Exports to sales %29.20-   
Imports to sales %6.30-   
Exports (fob) Rs m3,900NA-   
Imports (cif) Rs m847NA-   
Fx inflow Rs m4,356528 825.1%   
Fx outflow Rs m1,1627,193 16.2%   
Net fx Rs m3,194-6,665 -47.9%   
CASH FLOW
From Operations Rs m1,1192,360 47.4%  
From Investments Rs m-8533,008 -28.4%  
From Financial Activity Rs m-334-5,108 6.5%  
Net Cashflow Rs m-68260 -26.2%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 15.1 10.2 148.0%  
FIIs % 3.0 23.8 12.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 15.4 205.8%  
Shareholders   20,176 102,036 19.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 23, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS